These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
485 related articles for article (PubMed ID: 32860448)
1. Effects of neoadjuvant chemotherapy with or without intensity-modulated radiotherapy for patients with rectal cancer. He F; Yu L; Ding Y; Li ZH; Wang J; Zheng J; Chen HY; Liu S; Pang XL; Ajani JA; Wan XB Cancer Sci; 2020 Nov; 111(11):4205-4217. PubMed ID: 32860448 [TBL] [Abstract][Full Text] [Related]
2. Survival outcomes of different neoadjuvant treatment regimens in patients with locally advanced rectal cancer and MRI-detected extramural venous invasion. Chen M; Ma Y; Song YW; Huang J; Gao YH; Zheng J; He F Cancer Med; 2023 Nov; 12(21):20523-20537. PubMed ID: 37864414 [TBL] [Abstract][Full Text] [Related]
3. [Comparison of long-term efficacy between watch and wait strategy and total mesorectal excision in locally advanced rectal cancer patients with clinical complete response after neoadjuvant therapy]. Wang XH; Zhou CJ; Zhang S; Wang QX; Xiao WW; Ding PR; Chen G; Pan ZZ; Zeng ZF; Gao YH Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):266-273. PubMed ID: 32192306 [No Abstract] [Full Text] [Related]
4. Improved Metastasis- and Disease-Free Survival With Preoperative Sequential Short-Course Radiation Therapy and FOLFOX Chemotherapy for Rectal Cancer Compared With Neoadjuvant Long-Course Chemoradiotherapy: Results of a Matched Pair Analysis. Markovina S; Youssef F; Roy A; Aggarwal S; Khwaja S; DeWees T; Tan B; Hunt S; Myerson RJ; Chang DT; Parikh PJ; Olsen JR Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):417-426. PubMed ID: 28871992 [TBL] [Abstract][Full Text] [Related]
5. Association between adjuvant chemotherapy and survival in patients with rectal cancer and pathological complete response after neoadjuvant chemoradiotherapy and resection. He F; Ju HQ; Ding Y; Jiang Z; Li Z; Huang B; Wang X; Zhao Y; Li Y; Qi B; Luo W; Zhang Z; Pei Q; Chen H; Liu S; Pang X; Zheng J; Wang J; Ajani JA; Wan XB Br J Cancer; 2020 Oct; 123(8):1244-1252. PubMed ID: 32724220 [TBL] [Abstract][Full Text] [Related]
6. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer]. Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307 [No Abstract] [Full Text] [Related]
7. College of American Pathologists Tumor Regression Grading System for Long-Term Outcome in Patients with Locally Advanced Rectal Cancer. Chen HY; Feng LL; Li M; Ju HQ; Ding Y; Lan M; Song SM; Han WD; Yu L; Wei MB; Pang XL; He F; Liu S; Zheng J; Ma Y; Lin CY; Lan P; Huang MJ; Zou YF; Yang ZL; Wang T; Lang JY; Orangio GR; Poylin V; Ajani JA; Wang WH; Wan XB Oncologist; 2021 May; 26(5):e780-e793. PubMed ID: 33543577 [TBL] [Abstract][Full Text] [Related]
8. Identification of patients with locally advanced rectal cancer eligible for neoadjuvant chemotherapy alone: Results of a retrospective study. Han YM; Qi WX; Wang SB; Cao WG; Chen JY; Cai G Cancer Med; 2023 Jun; 12(12):13309-13318. PubMed ID: 37148548 [TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemoradiotherapy improves survival in locally advanced adenocarcinoma of esophagogastric junction compared with neoadjuvant chemotherapy: a propensity score matching analysis. Li J; Zhao Q; Ge X; Song Y; Tian Y; Wang S; Liu M; Qiao X BMC Surg; 2021 Mar; 21(1):137. PubMed ID: 33731072 [TBL] [Abstract][Full Text] [Related]
10. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report]. Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308 [No Abstract] [Full Text] [Related]
11. Pretreatment MRI-detected extramural venous invasion as a prognostic and predictive biomarker for neoadjuvant chemoradiotherapy in non-metastatic rectal cancer: a propensity score matched analysis. Yang SY; Bae H; Seo N; Han K; Han YD; Cho MS; Hur H; Min BS; Kim NK; Lee KY; Lim JS Eur Radiol; 2024 Jun; 34(6):3686-3698. PubMed ID: 37994967 [TBL] [Abstract][Full Text] [Related]
12. Is neoadjuvant chemoradiotherapy always necessary for mid/high local advanced rectal cancer: A comparative analysis after propensity score matching. Zhang Y; Sun Y; Xu Z; Chi P; Lu X Eur J Surg Oncol; 2017 Aug; 43(8):1440-1446. PubMed ID: 28502421 [TBL] [Abstract][Full Text] [Related]
13. Prognostic analysis of rectal cancer patients after neoadjuvant chemoradiotherapy: different prognostic factors in patients with different TRGs. Tang YL; Li DD; Duan JY; Wang X Int J Colorectal Dis; 2024 Jun; 39(1):93. PubMed ID: 38896374 [TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Initial Results of a Phase III Trial. Mei WJ; Wang XZ; Li YF; Sun YM; Yang CK; Lin JZ; Wu ZG; Zhang R; Wang W; Li Y; Zhuang YZ; Lei J; Wan XB; Ren YK; Cheng Y; Li WL; Wang ZQ; Xu DB; Mo XW; Ju HX; Ye SW; Zhao JL; Zhang H; Gao YH; Zeng ZF; Xiao WW; Zhang XP; Zhang X; Xie E; Feng YF; Tang JH; Wu XJ; Chen G; Li LR; Lu ZH; Wan DS; Bei JX; Pan ZZ; Ding PR Ann Surg; 2023 Apr; 277(4):557-564. PubMed ID: 36538627 [TBL] [Abstract][Full Text] [Related]
15. Changes in serum uric acid, serum uric acid/serum creatinine ratio, and gamma-glutamyltransferase might predict the efficacy of neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer. Shao Z; Xu Y; Zhang X; Zou C; Xie R Strahlenther Onkol; 2024 Jun; 200(6):523-534. PubMed ID: 37286741 [TBL] [Abstract][Full Text] [Related]
16. mFOLFOXIRI versus mFOLFOX6 as neoadjuvant chemotherapy in locally advanced rectal cancer: A Propensity Score Matching Analysis. Ding M; Zhang J; Hu H; Cai Y; Ling J; Wu Z; Xie X; Li J; Li W; Deng Y Clin Colorectal Cancer; 2022 Mar; 21(1):e12-e20. PubMed ID: 34963563 [TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant Therapy for Locally Advanced Esophageal Cancer Should Be Targeted to Tumor Histology. Stiles BM; Kamel MK; Harrison SW; Rahouma M; Lee B; Nasar A; Port JL; Altorki NK Ann Thorac Surg; 2019 Jan; 107(1):187-193. PubMed ID: 30278165 [TBL] [Abstract][Full Text] [Related]
18. GOLPH3 overexpression correlates with poor response to neoadjuvant therapy and prognosis in locally advanced rectal cancer. Zhu K; Zhao Q; Yue J; Shi P; Yan H; Xu X; Wang R Oncotarget; 2016 Oct; 7(42):68328-68338. PubMed ID: 27634904 [TBL] [Abstract][Full Text] [Related]